Jeffrey S Isenberg (Jeffery S Isenberg)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Ischemia Reperfusion Injury

Top Venues

Cell transplantation

bioRxiv : the preprint server for biology

Clinical and translational medicine

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Robert L Zondervan, Christina A Capobianco, Daniel C Jenkins, John D Reicha, Livia M Fredrick, Charles Lam, Jeffrey S Isenberg, Jaimo Ahn, Ralph S Marcucio, Kurt D Hankenson
CD47 is Required for Mesenchymal Progenitor Proliferation and Fracture Repair. bioRxiv : the preprint server for biology (2024)
Robert L Zondervan, Christina A Capobianco, Daniel C Jenkins, John D Reicha, Livia M Fredrick, Charles Lam, Jeffrey S Isenberg, Jaimo Ahn, Ralph S Marcucio, Kurt D Hankenson
CD47 is Required for Mesenchymal Progenitor Proliferation and Fracture Repair. bioRxiv : the preprint server for biology (2024)
Jeffrey S Isenberg, Enrique Montero
Tolerating CD47. Clinical and translational medicine 14 (2) (2024)
Jeffrey S Isenberg, Enrique Montero
Tolerating CD47. Clinical and translational medicine 14 (2) (2024)
Enrique Montero, Jeffrey S Isenberg
The TSP1-CD47-SIRPα interactome: an immune triangle for the checkpoint era. Cancer immunology, immunotherapy : CII (2023)
Fouad Kandeel, Mohamed El-Shahawy, Gagandeep Singh, Donald C Dafoe, Jeffrey S Isenberg, Arthur D Riggs
Towards a Rational Balanced Pancreatic and Islet Allocation Schema. Cell transplantation 30 (2022)
Hirotake Komatsu, Meirigeng Qi, Nelson Gonzalez, Mayra Salgado, Leonard Medrano, Jeffrey Rawson, Chris Orr, Keiko Omori, Jeffrey S Isenberg, Fouad Kandeel, Yoko Mullen, Ismail H Al-Abdullah
A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice. Cell transplantation 30 (2022)